News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research
Daniel Jones/LinkedIn
Jan 29, 2025, 14:11

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research

Daniel Jones,

“I had the privilege of attending ASCO GI to present our team’s research, led by Dr. Kyaw Thein! We were honored to have three meta-analyses accepted for presentation and publication in the Journal of Clinical Oncology.

Here are the links to our research for those interested in exploring them further.”

1. Meta-analysis of randomized controlled trials (RCTs) to evaluate the incidence of hemorrhage and venous thromboembolism (VTE) events in patients with gastrointestinal (GI) cancers treated with fruquintinib.

2. Meta-analysis of phase II/III randomized controlled trials (RCTs) to determine the incidence of hypertension and proteinuria in patients with gastrointestinal (GI) cancers treated with fruquintinib.

3. Meta-analysis of phase II/III randomized controlled trials (RCTs) to evaluate the incidence of hand-foot skin reaction (HFSR) or palmar-plantar erythrodysesthesia (PPE) syndrome in patients with gastrointestinal (GI) cancers treated with fruquintinib.

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research

ASCO GI 2025 cancer Daniel Jones Journal of Clinical Oncology Kyaw Thein OncoDaily Oncology
Special Coverage
Blog
Jan 29, 2025, 14:11
Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research
Blog
Jan 29, 2025, 14:08
One week to go until World Cancer Day! - UICC
Dialogues
Jan 29, 2025, 13:19
BGICC25 Updates: Dr. Matti Aapro on CDK4/6 Inhibitors in Breast Cancer
Science
Jan 29, 2025, 13:17
Myeloma Paper of the Day, January 29th, suggested by Robert Orlowski
Science
Jan 29, 2025, 12:53
Leo Mascarenhas: Elective Discontinuation of Larotrectinib in Pediatric Patients with TRK Fusion Sarcomas and Related Mesenchymal Tumors
Science
Jan 29, 2025, 12:52
No survival benefit from NAC in bladder cancer
Blog
Jan 29, 2025, 12:51
Sarah Louden: Join Total Health for "Best of Heme" on February 10th
Science
Jan 29, 2025, 12:36
Erman Akkus: KRAS inhibitors and mCRC
Blog
Jan 29, 2025, 12:35
Rachna Shroff: The women in GI Oncology who are moving the needle
Blog
Jan 29, 2025, 12:11
Theresia Christian: Paint for cancer awareness event by the Cancer Fight Tanzania
Blog
Jan 29, 2025, 12:09
AACR - A Therapeutic HPV Vaccine Could Eliminate Precancerous Cervical Lesions
Blog
Jan 29, 2025, 12:07
Celebrating Life: A Stem Cell Recipient Meets Her Donor at the NMDP ONE Forum - Dana-Farber Cancer Institute